Monday, February 25, 2019

2019 NIAID Omnibus Broad Agency Announcement

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases

NIAID News Twitter   NIAID Facebook   NIAID News Twitter   Youtube
Visit us on the Web

The 2019 NIAID Omnibus Broad Agency Announcement has been posted for Solicitation Number HHS-NIH-NIAID-BAA2019-1. Two NIAID divisions are accepting proposals for the following research areas:

NIAID Division of Allergy, Immunology, and Transplantation

  • Research Area 001: Development of Radiation/Nuclear Medical Countermeasures

NIAID Division of Microbiology and Infectious Diseases

  • Research Area 002: Development of Therapeutic Products for Antibiotic Resistant Bacteria
  • Research Area 003: Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria

Visit FedBizOpps.gov to see the broad agency announcement and full solicitation for HHS-NIH-NIAID-BAA2019-1.


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment